Dominican Republic: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in the Dominican Republic

The Dominican prophylactic medicaments containing insulin market was estimated at $X in 2022, surging by 1.6% against the previous year. Overall, the total consumption indicated a tangible increase from 2012 to 2022: its value increased at an average annual rate of +4.0% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by -1.3% against 2020 indices. Prophylactic medicaments containing insulin consumption peaked at $X in 2020; however, from 2021 to 2022, consumption stood at a somewhat lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in the Dominican Republic

In value terms, prophylactic medicaments containing insulin production rose slightly to $X in 2022 estimated in export price. The total output value increased at an average annual rate of +2.3% from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The pace of growth appeared the most rapid in 2017 with an increase of 15%. Prophylactic medicaments containing insulin production peaked at $X in 2020; afterwards, it flattened through to 2022.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from the Dominican Republic

After six years of growth, overseas shipments of medicaments containing insulin but not antibiotics in measured doses decreased by -50% to X kg in 2022. Overall, exports recorded a abrupt decline. The growth pace was the most rapid in 2021 when exports increased by 100% against the previous year. The exports peaked at X kg in 2012; however, from 2013 to 2022, the exports stood at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin exports shrank to $X in 2022. Over the period under review, exports saw a dramatic setback. The growth pace was the most rapid in 2021 when exports increased by 6.5% against the previous year. Over the period under review, the exports attained the maximum at $X in 2012; however, from 2013 to 2022, the exports failed to regain momentum.

Exports by Country

Honduras (X kg) was the main destination for prophylactic medicaments containing insulin exports from the Dominican Republic, accounting for a approx. 100% share of total exports.

From 2012 to 2022, the average annual growth rate of volume to Honduras amounted to -17.7%.

In value terms, Honduras ($X) also remains the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from the Dominican Republic.

From 2012 to 2022, the average annual growth rate of value to Honduras stood at -24.0%.

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, picking up by 95% against the previous year. Overall, the export price, however, continues to indicate a abrupt downturn. The export price peaked at $X per ton in 2012; however, from 2013 to 2022, the export prices remained at a lower figure.

As there is only one major export destination, the average price level is determined by prices for Honduras.

From 2012 to 2022, the rate of growth in terms of prices for Honduras amounted to -7.7% per year.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into the Dominican Republic

In 2022, supplies from abroad of medicaments containing insulin but not antibiotics in measured doses increased by 118% to X tons, rising for the second year in a row after four years of decline. In general, imports saw significant growth. The pace of growth was the most pronounced in 2015 when imports increased by 471%. Over the period under review, imports attained the maximum in 2022 and are expected to retain growth in the immediate term.

In value terms, prophylactic medicaments containing insulin imports soared to $X in 2022. Over the period under review, imports enjoyed a significant increase. The growth pace was the most rapid in 2013 when imports increased by 431% against the previous year. Imports peaked in 2022 and are expected to retain growth in the immediate term.

Imports by Country

In 2022, Denmark (X tons) was the main prophylactic medicaments containing insulin supplier to the Dominican Republic, accounting for a 97% share of total imports. It was followed by Germany (X kg), with a 2.2% share of total imports.

From 2012 to 2022, the average annual growth rate of volume from Denmark totaled +185.1%.

In value terms, Denmark ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics in measured doses to the Dominican Republic, comprising 92% of total imports. The second position in the ranking was taken by Germany ($X), with a 7.3% share of total imports.

From 2012 to 2022, the average annual growth rate of value from Denmark amounted to +361.5%.

Import Prices by Country

In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, surging by 7.9% against the previous year. In general, the import price, however, continues to indicate a relatively flat trend pattern. The pace of growth was the most pronounced in 2020 an increase of 33% against the previous year. As a result, import price reached the peak level of $X per ton. From 2021 to 2022, the average import prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Germany ($X per ton), while the price for Denmark totaled $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Denmark (+61.9%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :